Across TCGA pan-cancer cohorts, RN7SKP264 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RN7SKP264’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RN7SKP264 RNA is repressed in tumor relative to normal tissue. In most cancer types RN7SKP264 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

BRCA, LUSC, and THCA are the cancer types where RN7SKP264 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SKP264 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	III,IV	−0.060	.031	2	view →
LUSC	All	All	+0.051	.030	1	view →
THCA	All	II,III,IV	+0.047	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RN7SKP264 RNA expression & survival · all RN7SKP264 data types